Literature DB >> 13051750

Mechanisms responsible for the origin and distribution of blood-borne tumor metastases: a review.

D R COMAN.   

Abstract

Entities:  

Keywords:  NEOPLASMS

Mesh:

Year:  1953        PMID: 13051750

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  32 in total

1.  DISSEMINATION OF CANCER WITH SPECIAL EMPHASIS ON VASCULAR SPREAD AND IMPLANTATION.

Authors:  W H COLE; S S ROBERTS; R S WEBB; F W STREHL; G D OATES
Journal:  Ann Surg       Date:  1965-05       Impact factor: 12.969

2.  [Experimental studies on metastasis formation of tumors in rats].

Authors:  D SCHMAHL; T RIESEBERG
Journal:  Z Krebsforsch       Date:  1958

3.  Malignant disease associated with vascular phenomena.

Authors:  A A WILLIAMS
Journal:  Br Med J       Date:  1954-07-10

4.  The liver as a site and source of cancer.

Authors:  G R CAMERON
Journal:  Br Med J       Date:  1954-02-13

5.  Tumor Cell Contamination of the Surgical Wound: Experimental and Clinical Observations.

Authors:  C G Thomas
Journal:  Ann Surg       Date:  1961-05       Impact factor: 12.969

6.  [Tumor cells in cadaver blood].

Authors:  J LUDWIG
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1961

7.  A criticism of the haematogenous theory of cancer metastasis.

Authors:  W I ONUIGBO
Journal:  Z Krebsforsch       Date:  1962

8.  Rates of aggregation, loss of anchorage dependence, and tumorigenicity of cultured cells.

Authors:  T C Wright; T E Ukena; R Campbell; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

9.  Case report 708: Metastasis of renal cell carcinoma to skeletal muscle (right trapezius).

Authors:  P L Munk; S Gock; R Gee; D G Connell; N F Quenville
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

10.  On the prevention of haematogenous tumor metastases rats. The role of the proteinase inhibitor "Trasylol".

Authors:  R Stein-Werblowsky
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.